Navigation Links
MULTAQ(R) (dronedarone) for Atrial Fibrillation or Atrial Flutter Now Available in the United States
Date:7/28/2009

BRIDGEWATER, N.J., July 28 /PRNewswire-FirstCall/ -- Sanofi-aventis (EURONEXT: SAN and NYSE: SNY) announced today that MULTAQ((R)) (dronedarone) 400 mg Tablets is now available in pharmacies in the United States. MULTAQ is an anti-arrhythmic drug indicated to reduce the risk of cardiovascular hospitalization in patients with paroxysmal or persistent atrial fibrillation (AF) or atrial flutter (AFL), with a recent episode of AF/AFL and associated cardiovascular risk factors (i.e., age >70, hypertension, diabetes, prior cerebrovascular accident, left atrial diameter greater than or equal to 50 mm or left ventricular ejection fraction [LVEF] <40%), who are in sinus rhythm or who will be cardioverted.

MULTAQ was recently approved by the U.S. Food and Drug Administration on July 1, 2009.

"MULTAQ may help patients with atrial fibrillation or atrial flutter stay out of the hospital, which is an important factor in treatment that is often not addressed," said Gerald V. Naccarelli, M.D., Chief, Division of Cardiology, Pennsylvania State University College of Medicine. "We welcome a new option that may help patients with Afib or Aflutter manage their disease."

In the landmark ATHENA trial, the efficacy and safety of MULTAQ was evaluated in patients with AF/AFL or a recent history of these conditions (71% of these patients had no heart failure, 29% had NYHA class I-III stable heart failure). This trial showed that MULTAQ 400 mg BID, in addition to standard therapy, reduced the combined endpoint of cardiovascular hospitalization or death from any cause by 24% (p<0.001) when compared to placebo, meeting the study's primary endpoint. This reduction was generally consistent across study subgroups based on baseline characteristics or medications. Patients taking MULT
'/>"/>

SOURCE sanofi-aventis
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related medicine news :

1. FDA Approves Multaq(R) for Patients with Atrial Fibrillation or Atrial Flutter
2. CardioFocus Receives CE Mark for Atrial Fibrillation Ablation Catheter
3. Atrial fibrillation linked to increased hospitalization in heart failure patients
4. Redesigned Corporate Identity and nowEDC Software Upgrade Reflect Datatrials Commitment To Stress Free Study Delivery
5. Atrial fibrillation in endurance athletes still poses problems for sports cardiologists
6. Frost & Sullivan: Momentum Mounting for Catheter Ablation Technologies in Treatment of Atrial Fibrillation
7. Health and Advocacy Leaders Mobilize to Bring Attention to Atrial Fibrillation, a Costly and Misunderstood Cardiovascular Disease
8. eCardio Launches NEW Atrial Fibrillation Information System (AFIS(TM))
9. Catheter Ablation Effective in Treating Atrial Fibrillation
10. For Atrial Fibrillation, Surveyed Experts Indicate That Multaq, Celivarone and ATI-2042 Have Advantages Over Propafenone in the Maintenance of Normal Sinus Rhythm
11. Larger Men at Greater Risk for Atrial Fibrillation
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/22/2015)... May 22, 2015 Medivo, Inc., a leader ... Rates and Genotype Results in ‘Baby Boomers’ Screened for HCV ... Nationwide Lab Test Database” at Digestive Disease Week, May 16-19, ... Affairs and Analytics team members Carol Smyth, MB; Jason Bhan, ... Parker, MSI, along with Nancy Reau, MD from the University ...
(Date:5/22/2015)... May 22, 2015 Wimbledon Health Partners, ... electrocardiogram (EKG), echocardiogram and NCV testing , is ... highly respected All American National athlete, to the Wimbledon ... find the high level of testing and information it ... and their athletic trainers, this way they can focus ...
(Date:5/22/2015)... AZ (PRWEB) May 22, 2015 In ... Olympics, Parker and Sons is offering to donate $5 ... installing an AC unit or water softening system. Customers ... behalf; Parker and Sons gets business; and the Special ... , The Special Olympics helps over 4.4 million athletes, ...
(Date:5/22/2015)... 2015 Co founders Greenlee and James Chapko, ... general dentists to immediately deliver fully integrated dental implant services ... of the medical surgeon. , The Center, whose name ... general dentists from placing dental implants. These 6 roadblocks ... introduce the surgical placement of dental implants into his or ...
(Date:5/22/2015)... Maine (PRWEB) May 22, 2015 ... single-use swabs for the medical, diagnostic, environmental, and ... entire line of products in the US. At ... their operations outside the US, Puritan remains committed ... products at their Guilford, Maine facility. , Since ...
Breaking Medicine News(10 mins):Health News:Medivo Study Finds HCV Positivity Rates are 250% Higher Among Baby Boomers 2Health News:Wimbledon Athletics Recruits Team USA Athlete 2Health News:Wimbledon Athletics Recruits Team USA Athlete 3Health News:Parker and Sons is Proud to Support the Special Olympics with Their Everybody Wins Program 2Health News:First of Its Kind Dental Implant Training and Surgicenter to Open in June 2Health News:Maine Swab Company Celebrates 96 Years of American-made Products 2
... now have many more treatment options than in the ... derived by modifying substances found in humans or animals, ... the symptoms. The cost of biologic DMARDs is a ... 100 times more than a year,s supply of older, ...
... million people in America,have some form of epilepsy, a ... Treatment can be tough to get, though, for people,without ... This National Epilepsy Awareness Month, Pfizer wants to tell,you ... and women get,prescription medicines for free or at a ...
... Study finds twice the incidence of ,food insecurity, , , TUESDAY, ... smokers are more likely to be underfed and undernourished, a ... members of smoking households, but children feel the impact the ... at New York University School of Medicine. , "We know ...
... BlueCross announced the,launch of the only Blue branded dental ... Dental. No specific date was set for the,rollout of ... be available to,customers in 2009., "We believe that ... in our region because it carries the promise of ...
... DIEGO, Nov. 4 Accumetrics, Inc. announces the,appointment of ... of Operations and R&D. Mr. Dippel will oversee the ... are excited to have Bill join our team," said ... 33 years of,operations and R&D experience in the healthcare ...
... The American Society of,Hematology (ASH), the world,s largest ... to its Executive Committee, the,governing body of the ... January 2009., J. Evan Sadler, MD, PhD, ... by successive terms as president-elect and president. Charles,Abrams, ...
Cached Medicine News:Health News:Medicaid policies vary widely for rheumatoid arthritis drugs 2Health News:Smokers' Homes More Likely to House Hungry Kids 2Health News:Smokers' Homes More Likely to House Hungry Kids 3Health News:Accumetrics, Inc. Appoints William Dippel as Executive Vice President of Operations and R&D 2Health News:New Leadership Elected to the American Society of Hematology 2
(Date:5/22/2015)... May 22, 2015   InspireMD, Inc. (NYSE MKT: ... protection systems ("EPS"), today announced that its CGuard TM ... principle investigator Prof. Piotr Musialek , at the ... Paris, France . PARADIGM, an investigator-initiated ... c A roti D revascularization I n symptomatic ...
(Date:5/22/2015)... Today, Rhodes Pharmaceuticals L.P. announced that Aptensio ... for the treatment of Attention-Deficit/Hyperactivity Disorder (ADHD) will ... The announcement comes just one month ... Food and Drug Administration (FDA). ... capsule with an onset of effect of 1 ...
(Date:5/22/2015)... , May 22, 2015 ... clinical research unit with a worldwide reputation for ... its frequent publications in peer reviewed medical journals. ... stakeholders and regulators in discussions about rules for ...      (Logo: http://photos.prnewswire.com/prnh/20150522/745125) , Clinical ...
Breaking Medicine Technology:InspireMD's CGuardTM Highlighted at Clinical Presentation at EuroPCR 2015 Conference 2InspireMD's CGuardTM Highlighted at Clinical Presentation at EuroPCR 2015 Conference 3InspireMD's CGuardTM Highlighted at Clinical Presentation at EuroPCR 2015 Conference 4Rhodes Pharmaceuticals Announces Launch of New, Once-Daily Treatment for ADHD 2Rhodes Pharmaceuticals Announces Launch of New, Once-Daily Treatment for ADHD 3Rhodes Pharmaceuticals Announces Launch of New, Once-Daily Treatment for ADHD 4Rhodes Pharmaceuticals Announces Launch of New, Once-Daily Treatment for ADHD 5Rhodes Pharmaceuticals Announces Launch of New, Once-Daily Treatment for ADHD 6
... Soligenix, Inc. (Soligenix or the Company) (OTC Bulletin ... today announced that it has entered into a definitive ... novel technology for use in the development of subunit ...  The technology is the subject of several United States ...
... PARSIPPANY, N.J., Jan. 27, 2011 Significant flooding occurred ... and early January 2011.  Thousands of residents were affected. ... was launched on 29 December 2010, by Premier of ... who pitched in to help their fellow citizens clean-up ...
Cached Medicine Technology:Soligenix Executes Exclusive License with the University of Colorado for Vaccine Thermostabilization Technology 2Soligenix Executes Exclusive License with the University of Colorado for Vaccine Thermostabilization Technology 3Soligenix Executes Exclusive License with the University of Colorado for Vaccine Thermostabilization Technology 4DSM Joins International Response to Flooding in Australia 2DSM Joins International Response to Flooding in Australia 3
Male Support Brief...
For Lipoplasty or surgery of abdomen, flanks and midriff...
Select Support Brief...
Female High Waist Briefs...
Medicine Products: